NEW YORK — EDX Medical Group said on Monday that it has a signed a memorandum of understanding with UK-based healthcare group Spire Healthcare around diagnostic products and testing services.

Last week, readers were most interested in a story about reports of a possible sale by Thermo Fisher Scientific of parts of its diagnostics business.

NEW YORK – Scope Biosciences has secured €1 million ($1.2 million) in follow-on investment to scale its molecular diagnostics platform. The diagnostics developer said on Monday that the investment ...

The acquisition is intended to expand the French firm's presence in sequencing-based infectious disease testing.

NEW YORK – Linear Diagnostics is hoping to build a broader test menu for its rapid molecular testing platform to complement its first test for sexually-transmitted infections, the development of which ...

NEW YORK – With new data and plans for additional clinical validation in the works, liquid biopsy firm PanGia Biotech is making strides toward commercialization of its urine-based prostate cancer ...

NEW YORK – University of Chicago spinout OrisDx said Tuesday that it has raised $4 million in seed funding and it will use the money to support the launch of its saliva-based molecular test for oral ...

The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.

NEW YORK – The US Food and Drug Administration in May granted 510(k) marketing clearances for tests for cancer and precancer disorders, Alzheimer's disease, infectious respiratory diseases, and risk ...

NEW YORK — Gut microbiome health startup 32 Biosciences said on Tuesday that it has raised $6 million in private funding, which it said will support the development of its first products.